Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP946101.RA-A8YjQc7xNEZ2XEb_pvpgIpWwwrMvDqjn0nTaGTuxa0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP946101.RA-A8YjQc7xNEZ2XEb_pvpgIpWwwrMvDqjn0nTaGTuxa0130_assertion type Assertion NP946101.RA-A8YjQc7xNEZ2XEb_pvpgIpWwwrMvDqjn0nTaGTuxa0130_head.
- NP946101.RA-A8YjQc7xNEZ2XEb_pvpgIpWwwrMvDqjn0nTaGTuxa0130_assertion description "[The observed association between MET Y1253D-activating point mutation and decreased distant metastasis-free survival in advanced HNSCC suggests that MET may be a potential target for specific treatment interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946101.RA-A8YjQc7xNEZ2XEb_pvpgIpWwwrMvDqjn0nTaGTuxa0130_provenance.
- NP946101.RA-A8YjQc7xNEZ2XEb_pvpgIpWwwrMvDqjn0nTaGTuxa0130_assertion evidence source_evidence_literature NP946101.RA-A8YjQc7xNEZ2XEb_pvpgIpWwwrMvDqjn0nTaGTuxa0130_provenance.
- NP946101.RA-A8YjQc7xNEZ2XEb_pvpgIpWwwrMvDqjn0nTaGTuxa0130_assertion SIO_000772 19639388 NP946101.RA-A8YjQc7xNEZ2XEb_pvpgIpWwwrMvDqjn0nTaGTuxa0130_provenance.
- NP946101.RA-A8YjQc7xNEZ2XEb_pvpgIpWwwrMvDqjn0nTaGTuxa0130_assertion wasDerivedFrom befree-20150227 NP946101.RA-A8YjQc7xNEZ2XEb_pvpgIpWwwrMvDqjn0nTaGTuxa0130_provenance.
- NP946101.RA-A8YjQc7xNEZ2XEb_pvpgIpWwwrMvDqjn0nTaGTuxa0130_assertion wasGeneratedBy ECO_0000203 NP946101.RA-A8YjQc7xNEZ2XEb_pvpgIpWwwrMvDqjn0nTaGTuxa0130_provenance.